Regulation of plasma ceramide levels with fatty acid oversupply: evidence that the liver detects and secretes de novo synthesised ceramide

Hepatic Ceramide May Mediate Brain Insulin Resistance and Neurodegeneration in Type 2 Diabetes and Non-alcoholic Steatohepatitis

(2017) Lascelles E. Lyn-Cook et al.   JOURNAL OF ALZHEIMERS DISEASE

Pigment Epithelium-Derived Factor Regulates Lipid Metabolism via Adipose Triglyceride Lipase

(2011) M. L. Borg et al.   DIABETES

Sphingolipids: agents provocateurs in the pathogenesis of insulin resistance

(2011) C. Lipina et al.   DIABETOLOGIA

Inhibition of De Novo Ceramide Synthesis Reverses Diet-Induced Insulin Resistance and Enhances Whole-Body Oxygen Consumption

(2010) J. R. Ussher et al.   DIABETES

Link between plasma ceramides, inflammation and insulin resistance: association with serum IL-6 concentration in patients with coronary heart disease

(2009) V. D. F. de Mello et al.   DIABETOLOGIA

An improved method to determine serine palmitoyltransferase activity

(2009) Markus F. Rütti et al.   JOURNAL OF LIPID RESEARCH

Plasma Ceramides Are Elevated in Obese Subjects With Type 2 Diabetes and Correlate With the Severity of Insulin Resistance

(2008) J. M. Haus et al.   DIABETES

Lipid profiling of FPLC-separated lipoprotein fractions by electrospray ionization tandem mass spectrometry

(2008) Philipp Wiesner et al.   JOURNAL OF LIPID RESEARCH